Here, we report that the de novo dominant variant p.Lys33Gln in SLC25A4 is clinically associated with mild myopathy despite significant mitochondrial pathology in muscle biopsy and functional data showing abolished ADP/ATP exchange in vitro. This evidence concerns the gene SLC25A4 and myopathy.